Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-007054

Chief Financial Officer acquired 2,520 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2023-03-01 Grant or award +1,260 $19.86 $25,024 2,846 D
Mokari Atabak Chief Financial Officer 2023-03-01 Grant or award +1,260 4,106 D
Loading xslF345X03/doc4.xml…